ABIRAKAST 250

Abirakast 250mg

Composition: Abiraterone 250mg

Therapeutic Class: Androgen biosynthesis inhibitor

Abirakast: Precision in Prostate Cancer Therapy

Abirakast is the oncologist-prescribed medicine for highly resistant prostate cancer.

Why Aprazer’s Abirakast?

• • Aprazer, committed to global healthcare equity, is the leading oncology medicine manufacturer and exporter that develops affordable advanced care therapeutics.
• • International Quality Standards – WHO-GMP certified
• • Affordable life-saving medicines
• • Available in 20 countries

What is Abirakast?

Abirakast constitutes Abiraterone, which is an anticancer drug used as targeted hormone therapy for prostate cancers.

Uses of Abirakast

• • Metastatic castration-resistant prostate cancer
• • Metastatic high-risk castration-sensitive prostate cancer

How does Abirakast work?

It inhibits androgen secretions, reduces testosterone signaling to tumor growth, thus shrinking the tumor and stopping its proliferation.

Common Side Effects of Abirakast

• • Hypokalemia
• • Fluid retention
• • Nausea
• • Diarrhea
• • Urinary Tract Infections
• • Elevated liver enzymes

Toxicities

• • Cardiovascular toxicity – Severe hypertension, Heart failure
• • Severe hypokalemia – palpitations
• • Adrenal insufficiency
• • Liver toxicity
• • Bone fractures
• • Renal toxicity

Contraindications

Not to be used in patients with:

• • Hypersensitivity or allergic reaction to the drug or its excipients
• • Abirakast is not recommended for use in women
• • Breastfeeding mothers
• • Pregnant women

Precautions

To be used cautiously in patients with:

• • Cardiac abnormalities
• • Hepatic impaired functions
• • Renal impaired functions

Warnings

Prescription drug to be used under medical supervision.

Important Safety and Monitoring Information

Abirakast requires regular monitoring for:

• • Hematological functions – blood count
• • Blood pressure
• • Liver functions
• • ECG
• • Regular monitoring of electrolytes